Austria (AT)

DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification (2024) Jurmeister P, Leitheiser M, Arnold A, Capilla EP, Mochmann LH, Zhdanovic Y, Schleich K, et al. Journal article Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy (2024) Saalfeld FC, Möller J, Christopoulos P, Wenzel C, Rasokat A, Wang XA, Vathiotis I, et al. Journal article Preoperative geriatric assessment to predict functional outcome after major urologic operations: Results from a multicenter study (2024) Graf S, Lutz J, Koneval L, Kalogirou C, Weiß SC, Bannert H, Taubert H, et al. Journal article Lethal Borna disease virus 1 infections of humans and animals – in-depth molecular epidemiology and phylogeography (2024) Ebinger A, Santos PD, Pfaff F, Dürrwald R, Kolodziejek J, Schlottau K, Ruf V, et al. Journal article Osteointegration of functionalised high-performance oxide ceramics: imaging from micro-computed tomography (2024) Migliorini F, Eschweiler J, Betsch M, Maffulli N, Tingart M, Hildebrand F, Lecouturier S, et al. Journal article Author Correction: A comprehensive multi-domain dataset for mitotic figure detection (Scientific Data, (2023), 10, 1, (484), 10.1038/s41597-023-02327-4) (2024) Aubreville M, Wilm F, Stathonikos N, Breininger K, Donovan TA, Jabari S, Veta M, et al. Journal article, Erratum Hodgkin lymphoma: hypodense lesions in mediastinal masses (2024) Damek A, Kurch L, Franke FC, Attarbaschi A, Beishuizen A, Cepelova M, Ceppi F, et al. Journal article Biomechanics of sound production in high-pitched classical singing (2024) Echternach M, Burk F, Köberlein M, Döllinger M, Burdumy M, Richter B, Titze IR, et al. Journal article Increasing control over biomineralization in conodont evolution (2024) Shirley B, Leonhard I, Murdock DJ, Repetski J, Świś P, Bestmann M, Trimby P, et al. Journal article Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024) Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al. Journal article